Wright Medical CEO Palmisano Will Oversee Ongoing Cost Cuts
This article was originally published in The Gray Sheet
Executive Summary
Newly appointed Wright Medical CEO Robert J. Palmisano’s near-term focus will include implementing an ongoing restructuring and cost-cutting plan, the first phase of which will be completed over the next nine months, according to the company.
You may also be interested in...
News In Brief
GE boosts cancer commitment
People In Brief
Wright Medical CEO resigns
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”